Implantable cardioverter defibrillator in MC Ljubljana. An overview from 1989–2005
Abstract
Abstract: It is now a scientifically proven fact that implantable cardioverter defibrillator (ICD) therapy is the therapy of first choice for patients at high risk of life-threatening ventricular tachyarrhythmias. A significant contribution to the accelerating acceptance of ICD therapy comes from the technological advances, which have reduced the morbidity and enhanced programming and diagnostics very similar to pacemaker therapy. In Medical Centre Ljubljana ICDs have been implanted since 1989, altogether 207 pieces in 153 patients. We evaluated the indications, pacing mode, ejection fraction, number of shocks and the concomitant pharmacological treatment.
Downloads
References
Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 2334– 51.
Arnsdorf MF, Kopp DE. General principles of implantable cardioverter defibrillator. In: Rose BD. UpToDate. Wellesley, MA: UpToDate; 2001.
Bigger JT. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002; 346: 931–2.
Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–83.
Kadish A. Prophylactic defibrillator implantation-toward an evidence based approach. N Engl J Med 2005; 352: 285–7.
Gillis AM. Prophylactic implantable cardioverter-defibrillators after myocardial infarction-not for everyone. N Engl J Med 2004; 351: 2540–2.
Brady GH, Lee KL, Mark DB, Poole JE, et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–37.
Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrilator (DAVID) trial. JAMA 2002; 288: 3115– 23.
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). ACC/AHA/NASPE guidelines for implantation of cardiac pacemakers and antiarrythmia devices: Indications for ICD therapy. In: Rose BD. UpToDate. Wellesley, MA: UpToDate; 2002.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
